#impsci#cancer#survivorship#orgtheory @wakeforestmed from @birkensarah & co. = three-headed benevolent research monster named Scheylex doing good, having fun
Join us today at 12:30pm EST for panel w/ @NCI_ImplSci ISC3 network focused on applying #impsci frameworks & methods for promoting health equity & eliminating cancer-related inequities w/ @AHuebschmann#NathalieHugent@KAschbrenner @AprilYOh- hope to see you there! #DIScience21
🕎In prep for an early Chanukah, Cheyenne asked the following: "Are there any Chanukah rom-coms?" A: https://t.co/yxuTe7RMqH Few are actually rom-coms. Most are only loosely Hanukkah-related; see Night Before Christmas description of "Seth Rogen dons a dorky Hanukkah sweater"
Join my team! I'm hiring a research associate @UrologyMSK to help support on going smoking cessation and testicular cancer survivorship research and grants. Send to interested folks / apply here: https://t.co/WNHcACr5Hd
DM w/ questions
Excited to launch Collaborative for Implementation Practice @UNC_SSW. Follow us @imppractice! We aspire to center the human experience in implementation to advance equity. https://t.co/EsS6X5kgUD @implementEIC @effectiveserv@robynmildon @Bianca_Albers @AnnetteBoaz@TCI_ca
Unlearning (often with substitution) critical for deimplementation of low value / harmful entrenched medical practices—some progress but still massive opportunities.
@helfrich_c@birkensarah@DrMParchman
Proud to present this on behalf of an all-star group - https://t.co/SdJ6IHA9Ow
An implementation strategy w/ clinical decision support tool plus provider education can increase use of evidence-based tobacco screening/treatment in VA clinics #impsci@gorejohn@UclaUrology@vahsrd
🙌Pumped to talk about #OTIS#DIscience21! We'll present brief summaries of 9 org theories for #impsci. Know something about #orgtheory? Want to contribute to our framework! Let us know! We've got $50 to thank you for your time 😁
👋Urologic oncologists! Who's got refs for stats on % patients w/hematuria risk-stratified by criterion? Age, sex, smoking are strongest predictors of bladder cancer. But what are the stratification-driving criteria? What % are stratified based on age alone? Age+sex, etc.?
🤔Overbooking or delaying follow-up visits for low-risk breast cancer survivors (5+ years post-Stage 0-3 diagnosis, no adjuvant therapy)? 📣If so, we want to hear! We're interested in empirical & anecdotal evidence of how cancer programs accommodate these patients (or not).
Important PRO work to help guide patient-centered care. 👇 #AYACSM#SurvOnc#Fertility#SexualHealth#BodyImage#PLOSONE: Feasibility, acceptability and appropriateness of a reproductive patient reported outcome measure f ... https://t.co/omfldfOpi8
We're refining methods developed by @AlexisKirk88 to identify core functions of #EBIs (what makes interventions work). Random cool finding: Must triangulate across stakeholders to see that you've got an🐘on your hands! @rbell23
Are you interested in learning more about the cancer needs of NC's Indigenous populations? Tune into the next @unc_cn Patient Centered Care lecture presented by @WFCancerEquity's Ronny Bell and @UNCpublichealth's Marc Emerson!
9/8 @ 12 pm
https://t.co/9ysupLOpVN